Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,220
archived clinical trials in
HIV / AIDS

Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Howard Brown Health Center
mi
from
Chicago, IL
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Howard Brown Health Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Community Research Initiative of New England
mi
from
Boston, MA
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Community Research Initiative of New England
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Be Well Medical Center
mi
from
Berkley, MI
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Be Well Medical Center
mi
from
Berkley, MI
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Henry Ford Hospital
mi
from
Detroit, MI
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Central West Clinical Research Inc
mi
from
St. Louis, MI
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Central West Clinical Research Inc
mi
from
St. Louis, MI
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
HIV Program Hennepin County Medical Center
mi
from
Minneapolis, MN
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
HIV Program Hennepin County Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Saint Michael's Medical Center
mi
from
Newark, NJ
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Saint Michael's Medical Center
mi
from
Newark, NJ
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
South Jersey Infectious Disease
mi
from
Somers Point, NJ
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
South Jersey Infectious Disease
mi
from
Somers Point, NJ
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
North Shore University Hospital--Division of Infectious Diseases
mi
from
Manhasset, NY
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
North Shore University Hospital--Division of Infectious Diseases
mi
from
Manhasset, NY
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Beth Israel Med Ctr
mi
from
New York, NY
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Beth Israel Med Ctr
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Carolinas Medical Center-Myer's Park Infectious Disease Clinic
mi
from
Charlotte, NC
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Carolinas Medical Center-Myer's Park Infectious Disease Clinic
mi
from
Charlotte, NC
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Wake Forest University Health Services
mi
from
Winston-Salem, NC
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Wake Forest University Health Services
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Philadelphia FIGHT
mi
from
Philadelphia, PA
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Philadelphia FIGHT
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
University of PA
mi
from
Philadelphia, PA
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
University of PA
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Central Texas Clinical Research
mi
from
Austin, TX
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Central Texas Clinical Research
mi
from
Austin, TX
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Trinity Health and Wellness Center/AIDS Arms, Inc.
mi
from
Dallas, TX
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Trinity Health and Wellness Center/AIDS Arms, Inc.
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Tarrant County Infectious Disease
mi
from
Fort Worth, TX
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Tarrant County Infectious Disease
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Gordon Crofoot MD, PA
mi
from
Houston, TX
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Gordon Crofoot MD, PA
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Therapeutic Concepts, P.A.
mi
from
Houston, TX
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Therapeutic Concepts, P.A.
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
DCOL Center for Clinical Research
mi
from
Longview, TX
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
DCOL Center for Clinical Research
mi
from
Longview, TX
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Clinical Alliance for Research & Education-Infectious Diseases, LLC (CARE-ID)
mi
from
Annandale, VA
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Clinical Alliance for Research & Education-Infectious Diseases, LLC (CARE-ID)
mi
from
Annandale, VA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Long Beach Education and Research Consultants
mi
from
Long Beach, CA
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Long Beach Education and Research Consultants
mi
from
Long Beach, CA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Stanford University
mi
from
Palo Alto, CA
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Kaiser Permanente Medical Group
mi
from
Sacramento, CA
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Kaiser Permanente Medical Group
mi
from
Sacramento, CA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Apex Research, LLC
mi
from
Denver, CO
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Apex Research, LLC
mi
from
Denver, CO
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Johns Hopkins University
mi
from
Lutherville, MD
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Johns Hopkins University
mi
from
Lutherville, MD
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Greiger Clinic
mi
from
Mt. Vernon, NY
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Greiger Clinic
mi
from
Mt. Vernon, NY
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Miriam Hospital
mi
from
Providence, RI
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Southwest Infectious Disease Clinical Research, Inc
mi
from
Dallas, TX
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Southwest Infectious Disease Clinical Research, Inc
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Gordon E. Crofoot MD PA
mi
from
Houston, TX
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Gordon E. Crofoot MD PA
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Swedish Medical Center
mi
from
Seattle, WA
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Swedish Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Clinical Research Puerto Rico
mi
from
San Juan,
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Clinical Research Puerto Rico
mi
from
San Juan,
Click here to add this to my saved trials
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated:  11/24/2015
UCLA CARE Center CRS
mi
from
Los Angeles, CA
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated: 11/24/2015
UCLA CARE Center CRS
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated:  11/24/2015
Univ. of Rochester ACTG CRS
mi
from
Rochester, NY
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated: 11/24/2015
Univ. of Rochester ACTG CRS
mi
from
Rochester, NY
Click here to add this to my saved trials
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated:  11/24/2015
Houston AIDS Research Team CRS
mi
from
Houston, TX
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated: 11/24/2015
Houston AIDS Research Team CRS
mi
from
Houston, TX
Click here to add this to my saved trials
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated:  11/24/2015
Stanford AIDS Clinical Trials Unit CRS
mi
from
Palo Alto, CA
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated: 11/24/2015
Stanford AIDS Clinical Trials Unit CRS
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated:  11/24/2015
Ucsf Hiv/Aids Crs
mi
from
San Francisco, CA
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated: 11/24/2015
Ucsf Hiv/Aids Crs
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated:  11/24/2015
University of Colorado Hospital CRS
mi
from
Aurora, CO
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated: 11/24/2015
University of Colorado Hospital CRS
mi
from
Aurora, CO
Click here to add this to my saved trials
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated:  11/24/2015
Massachusetts General Hospital Clinical Research Site (MGH CRS) CRS
mi
from
Boston, MA
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated: 11/24/2015
Massachusetts General Hospital Clinical Research Site (MGH CRS) CRS
mi
from
Boston, MA
Click here to add this to my saved trials
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated:  11/24/2015
Brigham and Women's Hospital Therapeutics Clinical Research Site (BWH TCRS) CRS
mi
from
Boston, MA
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated: 11/24/2015
Brigham and Women's Hospital Therapeutics Clinical Research Site (BWH TCRS) CRS
mi
from
Boston, MA
Click here to add this to my saved trials
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated:  11/24/2015
Washington University Therapeutics (WT) CRS
mi
from
St. Louis, MO
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated: 11/24/2015
Washington University Therapeutics (WT) CRS
mi
from
St. Louis, MO
Click here to add this to my saved trials
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated:  11/24/2015
Trillium Health ACTG CRS
mi
from
Rochester, NY
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated: 11/24/2015
Trillium Health ACTG CRS
mi
from
Rochester, NY
Click here to add this to my saved trials
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated:  11/24/2015
Cincinnati CRS
mi
from
Cincinnati, OH
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated: 11/24/2015
Cincinnati CRS
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated:  11/24/2015
Penn Therapeutics Crs
mi
from
Philadelphia, PA
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated: 11/24/2015
Penn Therapeutics Crs
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated:  11/24/2015
University of Pittsburgh CRS
mi
from
Pittsburgh, PA
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated: 11/24/2015
University of Pittsburgh CRS
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
HIV-discordant Couple Intrauterine Insemination
Intrauterine Insemination for HIV-discordant Couples
Status: Enrolling
Updated:  11/30/2015
Missouri Center for Reproductive Medicine & Fertility
mi
from
Columbia, MO
HIV-discordant Couple Intrauterine Insemination
Intrauterine Insemination for HIV-discordant Couples
Status: Enrolling
Updated: 11/30/2015
Missouri Center for Reproductive Medicine & Fertility
mi
from
Columbia, MO
Click here to add this to my saved trials
Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women Taking Complera
CID 1213 - Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women After Switching to Fixed Dose Combination of Rilpivirine, Emtricitabine and Tenofovir DF
Status: Enrolling
Updated:  11/30/2015
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women Taking Complera
CID 1213 - Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women After Switching to Fixed Dose Combination of Rilpivirine, Emtricitabine and Tenofovir DF
Status: Enrolling
Updated: 11/30/2015
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Pulmonary Substudy: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)
Pulmonary Substudy: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)
Status: Enrolling
Updated:  11/30/2015
Washington DC VA Medical Center
mi
from
Washington,
Pulmonary Substudy: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)
Pulmonary Substudy: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)
Status: Enrolling
Updated: 11/30/2015
Washington DC VA Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-infected Patients That Have Never Received Treatment
A Multicenter, Open-label, Randomized Study to Assess the Metabolics, Efficacy, and Safety of Once-daily Darunavir Versus Atazanavir in HIV-infected Treatment-naive Adult Patients
Status: Enrolling
Updated:  11/30/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-infected Patients That Have Never Received Treatment
A Multicenter, Open-label, Randomized Study to Assess the Metabolics, Efficacy, and Safety of Once-daily Darunavir Versus Atazanavir in HIV-infected Treatment-naive Adult Patients
Status: Enrolling
Updated: 11/30/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials